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Regulatory T (Treg) cells, whose identity and function
are defined by the transcription factor Foxp3, are
indispensable for immune homeostasis. It is unclear
whether Foxp3 exerts its Treg lineage specification
function through activemodification of the chromatin
landscape and establishment of new enhancers or by
exploiting a pre-existing enhancer landscape. Anal-
ysis of the chromatin accessibility of Foxp3-bound
enhancers in Treg and Foxp3-negative T cells
showed that Foxp3 was bound overwhelmingly to
preaccessible enhancers occupied by its cofactors
in precursor cells or a structurally related prede-
cessor. Furthermore, the bulk of Foxp3-bound Treg
cell enhancers lacking in Foxp3 CD4+ cells became
accessible upon T cell receptor activation prior to
Foxp3 expression, and only a small subset associ-
ated with several functionally important genes were
exclusively Treg cell specific. Thus, in a late cellular
differentiation process, Foxp3 defines Treg cell func-
tionality in an ‘‘opportunistic’’ manner by largely ex-
ploiting the preformed enhancer network instead of
establishing a new enhancer landscape.
INTRODUCTION
Lineage-specifying transcription factors (TFs) are defined by
their sufficiency and necessity to establish cell identity, coordi-
nate cellular differentiation, andmaintain developmentally estab-
lished transcriptional programs. Differential use of regulatory
elements defines most previously studied lineage-specific
gene expression programs (Odom et al., 2004; Heintzmanet al., 2009; Heinz et al., 2010; Natoli, 2010; Thurman et al.,
2012). Thus, it seems reasonable to suggest that lineage-
specifying TFs establish distinct differentiated cell states by
setting up novel enhancer repertoires (Mercer et al., 2011). On
the other hand, some activation-induced transcription factors,
such as the glucocorticoid receptor, largely utilize pre-estab-
lished enhancers to impart changes in gene expression (John
et al., 2011). These considerations raise the question of whether
a late-acting differentiation factor like Foxp3 exerts cell lineage
specification function by actively remodeling the chromatin
landscape and establishing a distinct new set of enhancers or
by exploiting an enhancer landscape prepared in precursor cells
by their earlier developmental history.
Foxp3, an X-chromosome-encoded member of the Forkhead
TF family, controls differentiation and function of regulatory T
(Treg) cells (Littman and Rudensky, 2010). This distinct and
stable lineage of suppressive CD4+ T cells is characterized by
a unique gene expression program and serves as a critical
guardian of immune homeostasis (Josefowicz and Rudensky,
2009; Rubtsov et al., 2010). Treg cell depletion in normal adult
mice results in a fatal lympho- and myeloproliferative disorder
with widespread inflammatory lesions (Kim et al., 2007). Foxp3
is both necessary and sufficient to confer suppressor capacity
to naive CD4+ T cells (Fontenot et al., 2003; Hori et al., 2003;
Khattri et al., 2003; Gavin et al., 2007). Foxp3 is induced during
thymic differentiation or upon activation of peripheral CD4+
T cells in response to T cell receptor (TCR) stimulation in combi-
nation with several other signals, including IL-2 and TGF-b.
Furthermore, forced expression of Foxp3 confers suppressor
function to Treg precursor cells, and Foxp3 ablation in mature
Treg cells results in loss of lineage identity and immunosuppres-
sive phenotype (Fontenot et al., 2003; Williams and Rudensky,
2007). However, an understanding of how Foxp3 coordinates
the differentiation of Treg cells and their distinct suppression
program is lacking.Cell 151, 153–166, September 28, 2012 ª2012 Elsevier Inc. 153
We examined chromatin accessibility of Foxp3-bound
enhancers in Treg cells and Foxp3 CD4+ T cells, which serve
as precursors during extrathymic Treg cell generation.
Genome-wide analysis of Foxp3 binding sites using chromatin
immunoprecipitation followed by high-throughput sequencing
(ChIP-seq) was combined with genome-wide analysis of en-
hancers using DNase I hypersensitive site sequencing (DNase-
seq). We found that Foxp3 was bound overwhelmingly to
enhancers already accessible in precursor CD4+Foxp3 T cells
prior to Foxp3 expression, with only 2% of all Foxp3-bound
enhancers observed in Foxp3+ Treg cells, but not in resting
Foxp3-negative T cells. However, even these seemingly Treg-
specific sites were mostly established in a Foxp3-independent
manner in response to TCR signaling except for a small subset
of exclusively Treg-restricted enhancers found in several genes
important for Treg cell function. Analysis of DNA sequences at
Foxp3 binding sites identified a Forkhead motif only in a small
subset of these DNA regions, suggesting cofactor contribution.
High-resolution DNase I footprinting analysis revealed similar
footprints in Foxp3-expressing Treg cells and Foxp3 CD4+
T cells for several Foxp3 cofactors, supporting the notion that
Foxp3 functions through pre-existing enhancers already bound
by cofactors. Moreover, a related transcription factor, Foxo1,
appeared to serve as a predecessor at many Foxp3-binding
loci in precursor cells, and its displacement in Treg cells by
Foxp3 resulted in downregulation of proximal genes.
Thus, Foxp3 does not substantially change the accessible
chromatin landscape but rather binds at previously established
enhancers with cofactors already present and establishes the
Treg cell transcriptional and functional programs likely by modi-
fication of transcriptional activity of these enhancers and by
recruiting additional nuclear factors. These results suggest that
late-acting lineage specification transcription factors like
Foxp3 can establish functionality and define identity of their
corresponding cell type by exploiting a subset of enhancers
pre-established in precursor cells and maintained in a poised
state by a distinct set of cofactors and predecessors.
RESULTS
A Similar Enhancer Landscape in Foxp3-Positive Treg
and Foxp3 CD4+ T Cells
To test whether Treg cells exhibit a unique set of enhancers,
supporting their distinct function and phenotype, we employed
DNase-seq, which affords the most reliable assessment of
genome-wide chromatin accessibility and regulatory element
activity (Thurman et al., 2012). Thus, we isolated nuclei from fluo-
rescence-activated cell sorting (FACS) purified Foxp3+ Treg and
Foxp3 CD4+ T cells and subjected them to DNase I digestion
followed by high-throughput sequencing to find DNase hyper-
sensitive sites (DHSs; Figure 1A and Figure S1 available online).
We identified more than 100,000 DNase I hypersensitive sites in
Treg and CD4+Foxp3 T cells, each corresponding to the most
accessible regions in the genome (Figure 1B). Unexpectedly,
the location and the extent of accessibility of more than 99%
of DHSs were similar between naive CD4+ T cells and Treg cells,
implying that very few alterations in chromatin accessibility
occur during differentiation of Treg cells from their precursors154 Cell 151, 153–166, September 28, 2012 ª2012 Elsevier Inc.(Figures 1B and S1). DHSs are found at UTRs, promoters,
CCCTC-binding factor (CTCF)-bound elements, and enhancers.
Indeed, comparison of ChIP-seq data sets for a variety of histone
marks versus DNase-seq data sets showed extremely strong
correlation between DHSs and histone marks that are tradition-
ally associated with enhancers, including H3K4me1 (The
ENCODE Project Consortium, 2012).
Although most DHSs were comparable in precursor CD4+
T cells and Treg cells, a small, but likely important, subset of
DHSs (<1% of all DHSs; 679 total) was found in Treg cells, but
not in naive Foxp3 CD4+ T cells. These new sites were located
near or within many Treg-cell-characteristic genes, including
Foxp3, Ctla4, and Helios (Figure 1B). In addition to those sites
newly accessible in Treg cells, 250 DHSs prominent in naive
Foxp3 CD4+ T cells were markedly diminished in Treg cells.
The observed differences in chromatin accessibility were associ-
ated with directionally consistent changes in the nearest gene’s
expression (Figure 1D). In contrast to the nearly identical DHS
landscape observed in Treg cells and their precursors, the
genome-wide DHS landscape of B cells, a sister lineage of
T cells, was markedly different from that of either T cell subset
(Figure 1C). Thus, these results suggest that Treg cells utilize
predominantly T cell-specific enhancers present in precursor
Foxp3-negative cells and that very few novel enhancers emerge
in Treg cells.
Foxp3 Binds Predominantly to Preaccessible Chromatin
Sites
The observation that very few regulatory elements are acces-
sible only in Treg cells raised the question as to whether Foxp3
binds preferentially to sites of accessible chromatin that
are Treg specific or to sites that are preaccessible in Foxp3-
negative precursor cells. To address this question, we per-
formed ChIP-seq analysis of the genome-wide binding sites of
Foxp3 in purified Treg cells. Foxp3 was bound at more than
2,800 sites across the genome associated with more than
1,400 genes (Figures 2A and S2). Foxp3 binding sites were highly
enriched in the promoters and first introns of genes (p < 1077
and p < 10300, respectively; binomial test), as were DHSs
(p < 10300 and p < 10300, respectively; binomial test), which
is consistent with direct Foxp3-mediated transcriptional regula-
tion of gene expression via binding to promoters and enhancers
(Figures 2B and S3). Foxp3-bound loci were also highly enriched
for genes differentially expressed in Treg cells relative to
precursor CD4+ T cells (Figure 2C). We confirmed association
of Foxp3 with up- and downregulation of gene expression by
stratifying the data across both Foxp3 peak ranks and the
magnitude of gene expression changes (Figure S2). Foxp3
binding correlated with both up- and downregulated transcripts
in Treg cells known to be involved in T cell activation and regula-
tion by gene ontology.
We next identified regulatory elements that are bound by
Foxp3 and are similarly or differentially accessible between
Foxp3 CD4+ T cells and Treg cells. To do this, we cross-
referenced DNase-seq read counts with Foxp3 binding sites
(Figure 2D). Consistent with the observed broad distribution of
Foxp3 binding sites within the genome and overall similar
chromatin architecture of Treg cells and their precursors, 98%
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Figure 1. The Enhancer Repertoire Is Predominantly Identical in Treg and Foxp3 CD4+ T Cells
(A) Representative plots of DNase-seq reads aligned to the Ctla4 and Irf4 gene loci demonstrating DHS peaks that are shared by or are unique to the indicated
cell types. The vertical axis is in units of DNase I cleavage events per million mapped reads (RPM).
(B) Scatterplot of DHS peak RPM found in either Foxp3 or Foxp3+ T cells demonstrating new Treg-specific sites (red) and sites lost in Treg cells (blue).
(C) Scatterplot of DHS peak RPM identified upon analysis of Treg and B cells demonstrating T cell-specific sites (red) and B cell-specific sites (blue).
(D) Expression differences for genes with proximal DHSs with increased or decreased DNase accessibility (p values are from one-sided KS-test).
See also Figure S1.
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Figure 2. Foxp3 Predominantly Binds Preaccessible Sites
(A) Representative Foxp3 ChIP-seq reads aligned to the Ikzf2 gene locus.
(B) Localization of Foxp3 and DNase accessible sites demonstrating enrichment at promoters and within the first intron. Downstream distal sites are enriched
comparably to upstream distal sites.
(C) Genes bound by Foxp3 in Treg cells are enriched for differential expression compared to Foxp3 CD4+ T cells. Venn diagrams show significant overlap
between up- and downregulated genes and Foxp3-bound genes (hypergeometric tests). Cumulative distributions show quantitative shifts in expression of genes
bound by Foxp3 relative to all expressed genes (one-tailed KS tests).
(D) Representative plot of DNase-seq and ChIP-seq reads aligned to the Foxp3 locus illustrating Treg-specific DHS corresponding to a Foxp3 binding site.
(E and F) Foxp3 binding site accessibility is largely similar in Foxp3+ Treg and Foxp3 CD4+ cells. Scatterplot of all DHS peaks (black) and those containing
Foxp3-bound sites (pink) in the indicated cell populations.
See also Figures S2 and S3.
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of Foxp3 binding sites were observed to be already accessible,
i.e., DHS positive in CD4+ T cells (Figure 2E). The remaining
Foxp3 binding sites corresponded to Treg-specific enhancers,
including the previously identified CNS2 enhancer within the
Foxp3 locus (Figure 2D) responsible for the autoregulatory
feed-forward loop for stabilizing Foxp3 expression (Zheng
et al., 2010). A much larger proportion of Foxp3 binding was
observed at T cell-specific DHSs in contrast to Treg-specific
sites (29% T cell specific, 2% Treg specific; Figures 2E and
2F). Upon cross-referencing our DNase-seq data set and the
recent analysis of histone H3 modifications (Wei et al., 2009),
we observed significant overlap between the increased pres-
ence of H3K4me3 marks and newly accessible DHSs and also
between H3K27me3 marks and decreased chromatin accessi-
bility (Figure S2L).
These results indicated that Foxp3 does not dramatically alter
the chromatin accessibility landscape. Instead, it binds primarily
to already accessible enhancers and promoters in order to
coordinate the lineage-specific gene expression program of
Treg cells, which is consistent with the idea that Foxp3 exploits
chromatin features established during differentiation of Treg
precursor cells.
Foxp3 Binds through a Network of Cofactors
Given that Foxp3 predominantly binds to chromatin that is
accessible in Foxp3 CD4+ T cells, we next wanted to know
whether proteins occupying these sites in precursor cells might
serve as cofactors to facilitate Foxp3 recruitment to or function
at these sites. Foxp3 is known to physically interact with several
transcription factors. To explore whether any of these factors
could associate with Foxp3 binding sites, we examined
Foxp3 binding regions for the presence of known and novel
motifs. Significant enrichment for canonical ETS, RUNX,
CNOT, and Forkhead (FKHD) motifs (as defined by TRANSFAC
and JASPAR) accounted for 58% of Foxp3-occupied sites
(p < 10270, comparison to flanking region; Fisher’s exact
test), whereas the remaining peaks contained weaker motifs
(Figures 3A, 3B, and S4). As Foxp3 contains a Forkhead domain
that can bind to the canonical FKHD motif (Koh et al., 2009), it
was surprising that ETS and RUNX motifs were substantially
more enriched at Foxp3 binding sites than the FKHD motif
(Figure 3B). These motifs were also enriched in the Foxp3 peaks
with the highest rank by read count (Figure 3C). Furthermore,
ETS and RUNX motifs were enriched at Foxp3-bound loci rela-
tive to genome-wide DHS sites (Figures S4B and S4C). It is note-
worthy that our recent mass spectrometric analysis identified
ETS family members, Cnot3 and Runx1 (and its cofactor Cbfb),
as components of Foxp3 transcriptional complexes (Rudra
et al., 2012).
Next, we employed ChIP-seq to test whether several tran-
scription factors, whose DNA-binding motifs were enriched at
sites occupied by Foxp3, were bound to these sites. These
experiments confirmed binding of ETS family members Ets1
and Elf1, as well as Runx/Cbfb to Foxp3-occupied loci (Fig-
ure 3D); the binding was specifically enriched at Foxp3 sites
with corresponding motifs (Figure 3E). These results suggested
that Foxp3 and several transcription factors co-occupy a large
portion of Foxp3 binding sites in Treg cells and raised thepossibility that these cofactors are associated with the mainte-
nance of preformed accessible sites in precursor cells and
facilitate Foxp3 recruitment to these regulatory elements.
Foxp3-Binding Loci AreBoundbyCofactors in Precursor
Cells
To better understand the role of DNA-binding cofactors in
precursor cells, we wanted to determine whether Foxp3
cofactors were directly associated with DNA already in naive
Foxp3 CD4+ T cells. Thus, we generated and analyzed deeply
sequenced DNase-seq libraries (400 million reads each) to
identify DHSs that contained cofactor motifs preferentially pro-
tected from DNase I cleavage, indicating direct protein binding
(Neph et al., 2012). These maps allowed genome-wide identifi-
cation of specific protein-protected DNA footprints and provided
evidence for specific DNA-protein interactions in situ.
Genome-wide highly occupied FKHD motifs were observed
to be enriched for Foxp3 binding sites (Figures 4A and S5).
To gain further insights into these particular protein-DNA inter-
actions, the number of reads at individual nucleotides of acces-
sible regions of the genome was aligned to the same motif, and
a corresponding map of contacts was observed, which is
consistent with conservation of the nucleotides and previously
published crystal structures (Tahirov et al., 2001; Bandukwala
et al., 2011). Footprints of distinct sizes and patterns were found
for the FKHDmotif and cofactor motifs, including ETS and RUNX
(Figure 4B).
We next wanted to know whether these motifs were preferen-
tially protected in Treg versus Foxp3 CD4+ cells and whether
Foxp3 presence was correlated with alterations of the footprint.
To determine whether cofactors binding to these motifs were
prebound to regulatory DNA elements prior to Treg cell differen-
tiation and expression of Foxp3, per-nucleotide cleavage was
analyzed in precursor Foxp3 CD4+ cells (Figure 4B). Interest-
ingly, similar footprints were observed for the Foxp3 binding
sites containing ETS and RUNX, as well as FKHD motifs in
Treg cells and corresponding sites in Foxp3 CD4+ T cells, sug-
gesting that this group of Foxp3 binding sites is prebound
and protected in precursor cells. Consistent with the footprint-
ing results, binding of Runx/Cbfb and Ets family members to
corresponding sites in precursor Foxp3 CD4+ cells was
confirmed by ChIP-seq experiments, suggesting that Foxp3-
independent cofactor binding was significantly enriched at sites
of Foxp3 peaks when the corresponding cofactor motifs were
present (Figure 4C). Furthermore, Elf1 and Foxp3 cobound
loci showed highly similar quantitative binding patterns of Elf1
in Treg and Foxp3 CD4+ cells (Figure 4D). Thus, at a large
portion of its overall binding sites within the Treg cell genome,
Foxp3 binds indirectly, likely via interactions with its cofactors
prebound in precursor cells or directly via substantially weaker
FKHD motif(s).
Foxo1 Acts as a ‘‘Predecessor’’ and Is Displaced
by Foxp3
As Foxp3 binding sites are predominantly accessible in
precursor cells and as infrequent alterations of DNase footprints
in Treg cells were observed, we hypothesized that Foxp3 cofac-
tors might maintain the enhancer chromatin state to allow forCell 151, 153–166, September 28, 2012 ª2012 Elsevier Inc. 157
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Figure 3. Foxp3 Cofactors Are Bound at Preaccessible Enhancers Prior to Foxp3 Expression
(A) Motifs within Foxp3 binding sites identified by sequence analysis of ChIP-seq peaks and corresponding motif enrichment plots. Flanking regions were
sampled 200 bp away from centers of peaks.
(B) Proportion of Foxp3 binding sites that contain the indicated motifs or their combinations.
(C) Motif occurrence is enriched in Foxp3 peaks with more ChIP-seq reads.
(D) Representative plots of Ets-1 and Elf-1 ChIP-seq reads aligned to Foxp3 binding sites at the Junb gene locus.
(E) ChIP-seq analysis of Foxp3 cofactor occupancy at Foxp3-bound sites in Treg cells containing the corresponding motif demonstrates significant overlap
between cofactor and Foxp3 binding. ChIP signal is shown in units of RPM within a 200 bp window around Foxp3 peaks. Elf1 and Ets1 signal is transformed by
Log2(x+0.5) and Cbfb signal was transformed by Log2(x+1).
Error bars represent SD. See also Figure S4.Foxp3 binding during Treg cell lineage specification. Similar
DNase I cleavage patterns observed at Foxp3 binding sites con-
taining FKHDmotif in both Treg and Foxp3CD4+ T cells pointed
to the possibility that another Forkhead transcription family
member could serve as a ‘‘predecessor’’ at Foxp3 binding sites
in Foxp3 CD4+ cells. Foxp3 in Treg cells could then displace
this putative factor in a competitive manner, leading to changes
in gene expression. We considered the possibility that Foxo1,
a Forkhead TF family member, might serve the role of a Foxp3
predecessor bound to these sites in precursor cells because
Foxo1 has been implicated in regulation of gene expression in
both effector T cells and in Treg cells (Ouyang et al., 2009,
2010). Consistent with this idea, ChIP-seq analysis of Foxo1
binding showed that, in Foxp3 CD4+ T cells, Foxo1 was bound
to sites that were occupied by Foxp3 in Treg cells (Figure 5A).158 Cell 151, 153–166, September 28, 2012 ª2012 Elsevier Inc.Furthermore, in Treg cells, Foxo1 binding was preferentially
decreased at Foxp3-bound sites, but not at unbound sites, in
comparison to Foxp3 CD4+ cells (Figure 5B). We also excluded
the scenario that the observed decrease of Foxo1 at Foxp3-
bound sites in Treg cells is due to an overall decrease in chro-
matin accessibility because Foxp3-bound Foxo1 sites were on
average increased in accessibility (Figure S6).
Given that Foxo1 acts as a transcriptional regulator, its
displacement could be an important component of the Foxp3-
mediated program of gene repression. A corollary to this hypoth-
esis is that corresponding genes in precursor cells should be
either repressed or derepressed and exhibit diminished or
increased expression, respectively, in comparison to Treg cells,
where Foxp3 displaces its putative FKHD-containing prede-
cessor, Foxo1. Thus, we examined Foxp3-dependent gene
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Figure 4. Foxp3 Cofactors Are Present at Sites of Foxp3 Binding Prior to Foxp3 Expression
(A) Heatmaps showing per-nucleotide DNase I cleavage patterns and footprint occupancy at FKHD (left) and ETS (right) motifs within DHSs genome wide (black/
white heatmaps). The per-nucleotide conservation (phyloP) is increased at footprints (black/red heatmaps). Heatmaps are sorted by footprint occupancy at the
indicated motifs. FoxP3 occupancy by ChIP-seq is shown as gray tick marks in between the footprint and conservation heatmaps. Heatmaps are shown with
black indicating no signal and white/red as high signal.
(B) Foxp3 binding sites containing indicated motifs are similarly protected in Foxp3 CD4+ and Foxp3+ Treg cells. Heatmaps show per-nucleotide DNaseI
cleavage mapped around individual Foxp3 binding sites in Treg cells and Foxp3 CD4+ T cells aligned to the corresponding motif.
(C) ChIP-seq analysis of Ets1, Elf1, and Runx/Cbfb occupancy of Foxp3-bound sites containing ETS and RUNXmotifs, respectively, in Foxp3CD4+ T cells. Units
and transforms are the same as described in the Figure 3 legend.
(D) Elf1 binding at Foxp3-bound sites in both Foxp3CD4+ T cells and Treg cells revealed by ChIP-seq analysis. Spearman’s rank correlation is greater for Foxp3
binding sites with ETS motif than without. Data are incremented by 0.5 RPM to increase dynamic range.
Error bars represent SD. See also Figure S5.
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Figure 5. The Forkhead Transcription
Factor Family Member Foxo1 Serves as
a ‘‘Predecessor’’ of Foxp3 in Precursor Cells
(A) Representative plots of Foxp3 and Foxo1 ChIP-
seq reads from Treg and Foxp3 CD4+ T cells
aligned to the Lef1 and Jak1 gene loci. Foxo1 ChIP
was normalized by RPM and percentage of tags
in peaks.
(B) Differential Foxo1 binding at Foxp3 binding
sites in Foxp3+ Treg versus Foxp3 CD4+ T cells
(quantile normalized).
(C) Foxp3-bound genes that show a decrease in
Foxo1 binding in Treg cells versus Foxp3 CD4+
T cells exhibit decreased gene expression in Treg
cells compared to precursor cells.
See also Figure S6.expression changes by transcriptional profiling of Treg cells and
their precursors expressing a functional (Foxp3GFP) and null
Foxp3 reporter allele (Foxp3GFPKO), respectively. We found that
Foxp3-bound gene loci with a decreased Foxo1 occupancy
were significantly downregulated in Treg cells in contrast to
Foxp3-unbound genes or Foxp3-bound sites that have
increased Foxo1 (Figure 5C).
The observed gene repression associated with displacement
of Foxo1 by Foxp3 highlights its functional importance and
implicates Foxo1 as a functionally relevant predecessor at
Foxp3 direct binding sites in precursor cells. On a more general
level, displacement of a transcriptional regulator by a structurally
related TF with a similar DNA binding domain specificity repre-
sents a mode for implementation of gene expression program-
ming during cellular differentiation.
The Majority of ‘‘Treg-Specific’’ Enhancers Are
Established in a Foxp3-Independent Manner upon
T Cell Activation
We next wished to understand how apparently Treg-specific
enhancers are established. We found that, although an over-
whelming majority of Foxp3 binding sites exhibited an open
chromatin state in precursor CD4+ cells, the 679 loci identified
by DNase-seq as newly accessible in Treg cells were enriched
in genes known to be critical for Treg cell function. Additionally,
Foxp3 binding to these new DHSs in Treg cells was significantly
enriched in comparison to all DNase-accessible loci genome
wide (6% and 2%, respectively).
We wished to examine whether Foxp3 facilitates establish-
ment of these new sites through recruitment of chromatin re-
modelers or whether remodeling of these sites might precede160 Cell 151, 153–166, September 28, 2012 ª2012 Elsevier Inc.Foxp3 expression and occur indepen-
dently of it. To address these questions,
we first analyzed DNA sequence motifs
present at Treg-specific DHSs. We found
that they were highly enriched for the
AP-1 septamer motif (Figure 6A), and
the enrichment was prevalent in those
that were bound by Foxp3. AP-1 and its
binding partner NFAT are activated in
T cells upon TCR signaling (Macian,2005). Furthermore, thymic and extrathymic Treg cell differenti-
ation and Foxp3 induction require TCR stimulation by self or
nonself antigens (Josefowicz et al., 2012). Thus, the presence
of the AP-1 motif and necessity of TCR signaling for Treg cell
differentiation suggests that TCR signaling may be playing an
important role in the establishment of these enhancers in the
Treg cell lineage even prior to Foxp3 expression. In contrast
to AP-1 motif enrichment at newly accessible DHSs in Treg
cells, sites with Treg cell-specific diminished accessibility
were enriched for the RUNXmotif, along with a HMGmotif asso-
ciated with Lef1 and Tcf7 (Figure 6A).
In order to explore the role of TCR signaling in establishing
Treg-specific accessible chromatin loci, we performed DNase-
seq analysis of chromatin state in activated Foxp3 CD4+
T cells. For these experiments, activated Foxp3 CD4+ T cells
were FACS purified from Foxp3DTR mice after human diphtheria
toxin receptor (DTR)-expressing Treg cells were ablated upon
DT injection. Massive T cell activation observed upon Treg cell
ablation is dependent upon stimulation of TCR by self- and envi-
ronmental antigens (Kim et al., 2007). The vast majority of seem-
ingly Treg-specific enhancers (>75%) acquired an increase in
chromatin accessibility in activated cells, suggesting that TCR-
dependent T cell activation without Foxp3 expression is suffi-
cient to confer accessibility to these sites (Figures 6B and 6C).
Accordingly, genes associated with Treg-specific DHSs were
largely upregulated in Treg ‘‘wannabe’’ cells expressing
Foxp3GFPKO allele relative to Foxp3 CD4+ T cells (Figure 6D)
(Gavin et al., 2007). These cells most likely received TCR signals
and represent direct Treg cell precursors—which is reflected by
Foxp3 locus activation—but lack Foxp3 protein expression and
suppressor function.
A B C
D E
Figure 6. The Majority of ‘‘Treg-Specific’’ DHS Sites Are Established in a Foxp3-Independent Manner upon TCR-Dependent Activation of
Foxp3 CD4+ T Cells
(A) Scatterplot of DHSs in Treg versus Foxp3CD4+ T cells. An AP-1 motif was enriched at sites with an increased DNase sensitivity in Treg cells, whereas RUNX
and HMG motifs were enriched at sites with diminished DNase sensitivity.
(B and C) Scatterplot and CDF plots of DHS peaks found in naive and activated Foxp3 CD4+ T cells demonstrate that the majority of Treg-specific DNase sites
are present in activated Foxp3 CD4+ T cells.
(D) CDF plots of expression changes of genes containing ‘‘Treg-specific’’ DHS sites in GFP+Foxp3 T cells isolated from Foxp3GFPKO/WT heterozygous female
mice versus naive Foxp3 CD4+ or Foxp3+ Treg cells.
(E) CDF plots of expression changes of genes containing ‘‘Treg-specific’’ DHS sites in calcineurin B1-deficient and B1-sufficient Treg cells with impaired versus
unperturbed NFAT activation from Foxp3Cre/WT heterozygous females, respectively.
See also Figure S7.The Foxp3-independent expression of genes containing
‘‘Treg-specific’’ DHSs enriched for the AP-1 motif and chromatin
accessibility at these sites in activated, but not resting, Foxp3
CD4+ T cells suggested that activation of AP-1—most likely in
cooperation with NFAT—may account for these features. We
next examined whether the impairment in NFAT activation
upon ablation of calcineurin B1 in Foxp3CreCnb1fl/fl Treg cells dis-
proportionally affected the genes containing ‘‘Treg-specific’’
DHSs. In the absence of calcineurin signaling, a prerequisitefor NFAT activation and translocation to the nucleus, these genes
had significantly decreased expression, particularly those that
both contained an AP-1motif andwere Foxp3 bound (Figure 6E).
Importantly, loss of NFAT activation in Treg cells led to a loss of
their function and severe autoimmunity (data not shown).
The remaining subset of enhancers present in Treg cells, but
not in precursor Foxp3 CD4+ or activated CD4+ T cells, were
found in a subset of genes encoding Ccr6, Lrrc32 (GARP),
Foxp3, Itgb8, HOPX, Alk1, and PHLPP proteins, whose functionsCell 151, 153–166, September 28, 2012 ª2012 Elsevier Inc. 161
in Treg cells include regulation of Foxp3 and TGF-b expression
and activation, cell trafficking, and Akt signaling (Figure S7).
Treg-specific DHS loci that are not more accessible in activated
Foxp3 CD4+ T cells had markedly less AP-1 motif enrichment.
In accordance with the presence of Treg cell-specific Foxp3-
bound enhancers in these loci, these genes are expressed in
a Foxp3-dependent manner in Treg cells.
In addition to the aforementioned genes with a known role in
Treg cells, genes containing Treg-specific DHSs included genes
whose role in Treg cells is currently unknown. Together, these
genes may play an important role in Treg cell function under
homeostatic and inflammatory conditions. Consistent with the
latter idea, we found overlaps between Treg-specific DHSs
and several SNPs identified in genome-wide association studies
as associated with a variety of autoimmune and inflammatory
diseases (Figure S7). These include Il10 and Lrrc32 in ulcerative
colitis, Ccr6 in rheumatoid arthritis, and Rhoh in Graves’ disease
(Stahl et al., 2010; Anderson et al., 2011; Chu et al., 2011). These
results highlight the power of the data sets generated by com-
bined DHS-seq and Foxp3 ChIP-seq analyses and might offer
potential insights into the role of Treg cells in these diseases.
Taken together, our experiments suggest that more than 99%
of sites bound by Foxp3 in Treg cells are accessible in their
precursors and are occupied by Foxp3 cofactors or Foxo1
serving as a Foxp3 ‘‘placeholder’’ and also that TCR signaling
is responsible for Foxp3-independent establishment of the
remaining minor ‘‘Treg-specific’’ subset of Foxp3-bound
enhancers. Thus, Foxp3 controls Treg cell differentiation and
function by modulating gene expression upon binding to these
pre-existent enhancers without profound alterations in chro-
matin accessibility and enhancer repertoire.
DISCUSSION
Cell-type-specific gene expression and functional features of
differentiated cells are established by genetically defined
programs of specification, which employ epigenetic control
and transcriptional and posttranscriptional regulation. Recent
genome-wide studies of histone modifications indicate that cell
identity is largely defined by permissive or repressive chromatin
features present at enhancers (Heintzman et al., 2009; Mercer
et al., 2011). We examined the late differentiation process of
Treg lineage specification resulting from Foxp3 expression.
Treg cell differentiation is known to occur at a late stage of
thymocyte maturation and beyond the thymus as mature naive
Foxp3 CD4+ T cells acquire Foxp3 expression upon TCR stim-
ulation under particular conditions that give rise to extrathymic
Treg cells (Josefowicz et al., 2012). Our analysis of genome-
wide DNase-seq and Foxp3 ChIP-seq data sets demonstrates
that >99% of Foxp3-bound enhancers are accessible in
precursor Foxp3 CD4+ resting or activated T cells. Although
there may be subtle undetected changes in chromatin accessi-
bility imparted by Foxp3, DNase-seq technology offers the
most accurate means of genome-wide enhancer analysis
currently available (Thurman et al., 2012).
Interestingly, the lack of alterations in chromatin accessibility
imparted by Foxp3 contrasts with early cellular differentiation
processes, which are thought to rely on epigenetic modifications162 Cell 151, 153–166, September 28, 2012 ª2012 Elsevier Inc.of chromatin at regulatory gene loci that can persist even after
removal of the initiating factor (Cavalli and Paro, 1999). The
establishment of heritable cell lineage-specific enhancer reper-
toires is critical for early tissue development (Cirillo et al., 2002;
Heinz et al., 2010; Natoli, 2010; Mercer et al., 2011). Unlike early
differentiation defined by lineage-specification factors, gene
expression programs induced by some extracellular cues are
driven by ligand- or signaling-dependent mobilization of latent
transcription factors, which bind to preconditioned enhancers
to alter gene expression without substantially altering the chro-
matin landscape (John et al., 2011). It must be noted that certain
extracellular stimuli such as LPS that result in drastic changes in
gene expression may be associated with considerable changes
in chromatin states (Ghisletti et al., 2010; Smale, 2010).
Thus, features of late cellular differentiation exemplified by
Foxp3-dependent generation of Treg cells are similar to those
of responses triggered by extracellular stimuli like glucocorticoid
steroid receptor ligand response in that both are associated with
minimal chromatin remodeling (Biddie et al., 2011). Importantly,
these results can explain the previously demonstrated need
for continuous expression of Foxp3 for the maintenance of
suppressive function and phenotypic features in fully differenti-
ated Treg cells (Williams and Rudensky, 2007). This observation
may also extend to the reported requirement for continuous
expression of Pax5 in mature B cells, which may also be acting
through modulation of pre-existing enhancers instead of de
novo heritable alterations in chromatin state (Cobaleda et al.,
2007).
We also observed that, whereas the vastmajority of enhancers
were accessible in precursor CD4+ cells, 2% of Foxp3 binding
sites appeared to be accessible in a Treg-specific manner and
were found at important Treg cell signature gene loci. However,
a large majority of these sites emerged in activated T cells in a
Foxp3-independent manner. These sites were highly enriched
for a motif bound by AP-1, which is particularly interesting
because AP-1 forms protein complexes with NFAT to jointly
control expression of numerous genes downstream of TCR
signaling (Macian, 2005). Thus, we propose that TCR activa-
tion-driven mobilization of AP-1, likely in cooperation with
NFAT, facilitates chromatin remodeling at these ‘‘Treg-specific’’
enhancers in precursor cells and prepares sites for Foxp3
binding (Figure 7C). Furthermore, X-ray crystallographic analysis
has shown that Foxp3 forms protein complexes with NFAT and
is thought to displace AP-1 in the NFAT complex in its DNA-
bound form (Wu et al., 2006), which suggests that Foxp3
might replace AP-1 at activation-dependent enhancers in Treg
cells. Consistent with this idea, we found altered expression of
genes containing these enhancers in Treg cells subjected to
ablation of a conditional Cnb1 allele, resulting in impaired
NFAT activation. In conjunction with a recent study showing
that AP-1 maintains open chromatin, our data point to a general
role for AP-1 as a pioneer factor capable of establishing an
accessible chromatin state at regulatory elements in response
to extracellular stimuli in diverse biological contexts, including
both cellular differentiation and activation (Biddie et al., 2011).
We also note that T cell activation is able to substantially remodel
chromatin at multiple functionally important gene loci in addition
to TCR response elements, which were previously characterized
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Figure 7. Potential Modes of Utilization of
Preformed Enhancer Network by Foxp3
during Treg Cell Differentiation
(A) The majority of Foxp3 binding sites are found
within enhancers that are occupied by Foxp3
cofactors before Foxp3 is expressed and are
accessible in precursor cells.
(B) Foxp3 binds to sites occupied by a related
Forkhead transcription family member Foxo1,
which serves as a ‘‘placeholder’’ and can be dis-
placed by Foxp3.
(C) Foxp3 is recruited to enhancers primed in a
TCR signaling-dependent manner during Treg cell
differentiation likely via NFAT-AP1-assisted
chromatin remodeling.as primed to be preaccessible for rapid T cell response (Barski
et al., 2009).
Because Foxp3 seemed to not alter chromatin accessibility
directly, wewished to better understand alternativemechanisms
for how it implements the Treg cell lineage gene expression
program. Analysis of sequence patterns showed that a canonical
FKHD motif was present only in a minority of Foxp3 sites. In
contrast, a majority of sites contained motifs for Foxp3 cofac-
tors, including members of ETS and RUNX families of nuclear
factors. Thus, Foxp3 may interact with DNA in large part indi-
rectly, through protein-protein interactions. This result is consis-
tent with the observed loss-of-function mutations of Foxp3 in the
oligomerization leucine zipper domain in IPEX (immunodysregu-
lation, polyendocrinopathy, enteropathy, X-linked) syndrome
patients, which disrupts protein-protein interactions (Wildin
et al., 2002; Lopes et al., 2006; van der Vliet and Nieuwenhuis,
2007). This is also consistent with Foxp3 DNA binding properties
revealed by EMSA and crystallization studies (Koh et al., 2009;
Bandukwala et al., 2011) and by the large size of Foxp3 protein
complexes, which contain Runx/Cbfb and ETS family members,
among other cofactors (Rudra et al., 2012). Also, both Ets and
Runx/Cbfb play important roles in Treg cell differentiation and
function that can now be explained in part by their cooperation
with Foxp3 at its binding sites (Rudra et al., 2009; Mouly
et al., 2010). Genomic DNase I footprinting suggested that, inCell 151, 153–166, Seprecursor cells, these cofactors are
already present at sites of Foxp3 binding
prior to expression of Foxp3, and this
binding in precursor cells was confirmed
by ChIP. Thus, Foxp3 may be recruited
to these sites with prebound cofactors,
leading to conformational perturbation
or recruitment of other factors and
changes in gene expression (Figure 7A).
In addition to cobinding and directly
interacting cofactors, our results sug-
gested a mode of transcriptional regula-
tion through structural homologs of
transcription factors acting as predeces-
sors or placeholders. Analysis of Foxo1
and Foxp3 ChIP-seq and DNase-seq
data sets indicated that Foxp3 in Tregcells displaced another familymember, Foxo1, whichwas bound
to FKHD motif-containing enhancers in precursor cells (Fig-
ure 7B). Importantly, transcripts of genes associated with these
sites were predominantly downregulated genome wide in
a Foxp3-dependent manner. Previously, a swap of structurally
unrelated transcription factors at enhancers has been shown
to cause a change in gene expression (Sun et al., 2002; Reichard
et al., 2007). Thus, although Foxo1 and its relative Foxo3
enhance Treg cell function, possibly in part through Foxp3 induc-
tion (Ouyang et al., 2009, 2010), our results suggest an additional
role for Foxo family members in establishing or maintaining
enhancers for Foxp3. This mode of Foxp3 function raises an
exciting possibility that members of a given family of transcrip-
tion factors with distinct DNA binding specificity prepare or
preserve enhancers in precursor cells during differentiation (or
activation) to pass them on to another member of the same
family, which, through dislodgement of the predecessor, imparts
transcriptional activation or repression. This idea was supported
by an earlier observation that the Forkhead transcription factor
family member FoxD3 binds at an enhancer within the Alb1 locus
in embryonic stem cells and serves as a ‘‘placeholder’’ for Fox-
A1 and FoxA2, which, upon binding, promote chromatin remod-
eling and binding of GATA family members during definitive
endoderm and hepatocyte differentiation (Xu et al., 2009). This
‘‘evolutionary’’ model, in which a factor exploits highly similarptember 28, 2012 ª2012 Elsevier Inc. 163
structural domains for alternative means of transcriptional regu-
lation, offers an intuitive mechanism for maintenance of
enhancers in an ‘‘open’’ chromatin state and its engagement
by distinct members of different families of transcription factors.
Finally, our data sets of Foxp3 targets and Treg cell-specific
changes in enhancer repertoire identified a number of new regu-
latory targets, which may inform further exploration of mecha-
nisms and functions of Treg cells in human diseases. The
potential importance of these regulatory elements and genes
was suggested by the overlap of these data sets with SNPs
associated with a variety of clinical inflammatory conditions.
In summation, our results suggest several modes for ‘‘oppor-
tunistic’’ control of Treg cell differentiation and function by Foxp3
through a network of preformed enhancers and cofactors
operating in precursor cells. Foxp3 exploits the pre-existing
enhancer landscape by binding to its cofactor-occupied
enhancers accessible in precursor cells, by displacement of its
putative predecessor Forkhead family member Foxo1, and by
binding to TCR stimulation-dependent enhancers established
during Treg cell differentiation in a Foxp3-independent manner.
Thus, in contrast to early cellular differentiation characterized
by alteration of chromatin accessibility at key enhancers, late
differentiation relies overwhelmingly on a set of enhancers
established during developmental history of precursor cells
and on a minor set of enhancers established in precursor cells
in response to extracellular cues promoting differentiation of
a given cell type. However, given that, even in early develop-
ment, cells respond to extracellular cues from adjacent acces-
sory cells and soluble ligand gradients, it may very well be the
case that the mechanisms we describe here are also extensively
employed during early developmental processes.
EXPERIMENTAL PROCEDURES
Mice and Cell Sorting
Foxp3GFPKO, Foxp3GFP-DTR, and Foxp3Cre mice were previously described
(Gavin et al., 2007; Kim et al., 2007; Rubtsov et al., 2008). All of the mice
were bred and housed in the specific pathogen-free animal facility at the
Memorial Sloan-Kettering Cancer Center and were used in accordance with
institutional guidelines. Activated Foxp3 CD4+ T cells were sorted from
spleens and lymph nodes ofmice 10 days after two administrations of intraper-
itoneal diphtheria toxin (DT) (Sigma). CD4 T cells were isolated by CD4 Dyna-
beads positive selection (Invitrogen), followed by sorting using an Aria2 flow
cytometer (BD Biosciences).
Chromatin Immunoprecipitation of Foxp3 and Its Cofactors
Chromatin immunoprecipitation was performed as previously described
(Zheng et al., 2007). Briefly, nuclei were isolated and lysed in 0.2% SDS,
followed by sonication to fragment DNA to 200–300 bp fragments (Branson).
The chromatin was then incubated overnight with the appropriate antibody
(polyclonal rabbit Foxp3 antibody [Zheng et al., 2007], Ets1, Elf1, and Cbfß
antibodies [all Santa Cruz clones C-20, C-20, and FL-182]). Precipitated
chromatin was then washed, decrosslinked, and digested with proteinase K,
and DNAwas isolated by using QIAGEN PCR purification kit or phenol-chloro-
form extraction. ChIPwas validated by qPCR for known targets of correspond-
ing transcription factors. Sequencing libraries were prepared by ChIP-seq
DNA prep kit and sequenced using a Genome Analyzer IIx or HiSeq (Illumina).
Analysis of ChIP-Seq
DNA reads generated in DNase-seq and Foxp3 ChIP-seq experiments were
aligned to the UCSCmm9 genome using Bowtie allowing for two mismatches.
Only uniquely aligning reads were analyzed. For ChIP experiments, all reads164 Cell 151, 153–166, September 28, 2012 ª2012 Elsevier Inc.starting at an identical position were compressed to single reads to remove
monoclonal reads. ChIP-seq peaks were called using SPP, and peak-height
was determined by number of reads that aligned to a 200 bp window around
peak center after strand-specific 75 nt shift. Peaks with high input-control
signal were excluded from subsequent analysis. This included peaks with
input reads per million (RPM) greater than a threshold of 0.5 RPM and
peaks that were not enriched relative to input (p < 0.001) as determined by
a Poisson distribution using a local estimate (200 bp) of l. Several total peak
estimation methods were examined, and many analyses were done using
peak rank instead of discretized peak calls (Figure S2). The final number of
peaks for Foxp3 was determined by the overlap in top 5,000 peaks in both
replicates, resulting in 2,886 peaks. Peaks were assigned to genes by prox-
imity to gene body defined by transcription start and end sites. When
comparing multiple ChIP-seq experiments, peak heights were quantile
normalized to account for potential differences in experimental data quality.
When plotting tracks for multiple ChIP-seq experiments for a single transcrip-
tion factor, a multiplicative factor was used to normalize for enrichment, i.e.,
differing numbers of tags in peaks.
Chromatin Accessibility and DNase Footprinting
Treg and resting and activated Foxp3 T cells, as well as B cells, were assayed
for chromatin accessibility using DNase-seq as described elsewhere (John
et al., 2011). Briefly, intact nuclei were treated with DNase I, DNA was isolated
following nuclear lysis, and fragments sized 300–1,000 bp were sequenced.
DNase-seq data shown in scatterplots are in units of RPM and were
incremented by 0.3 (to smooth and avoid zeros), log-transformed, capped at
50 RPM, and quantile normalized. DNase-seq peaks (DHSs) were identified
as described in Thurman et al. (2012) by using FDR 1%.
Differential accessibility was determined by an asymmetric cutoff for
up- and downregulation of accessibility based on an empirical 5% FDR
derived from replicate-to-replicate differences and consistency in replicates
(Figures S1A and S1B). These loci were then confirmed independently when
comparing an additional replicate of Treg DNase-seq to two replicates of
CD4 DNase-seq (Figure S1C). This analysis revealed differential sites that
were ranked highly by rank expectation and negative binomial dispersion
approaches (data not shown) (Robinson et al., 2010; S. Thomas, S.N., A.R.,
and J.A.S., unpublished data).
Per-nucleotide DNase I cleavages were aggregated into heatmaps by align-
ing read start sites to specific motif instances (Figure S5) as described in Neph
et al. (2012). Conservation across placental mammals was analyzed by using
phyloP downloaded from UCSC genome browser.
Motif Analysis
For analysis of transcription factor bindingmotif enrichment, motifs were taken
from JASPAR and TRANSFAC, whereas de novo motifs (AP-1 and HMG) were
found by MDscan, cERMIT, and MEME motif discovery tools (Liu et al., 2002).
To determine motif presence at a ChIP-seq or DNase-seq peak, motifs were
scanned within 100 bp regions around peak centers. Motif scores were
defined as the log likelihood ratio of observing nucleotide frequency defined
by the PSSM compared to genome-wide nucleotide frequencies. Motifs
were considered present when the maximum PSSM score was greater than
that found in 90% of the maximum scores of the flanking regions. This can
be considered an empirical p value of 0.1 on the distribution of maximum
PSSM score over a given window. Although this threshold may seem
insufficiently stringent, when we examined regions considered positive for
the motif, we found that nearly all sites (>90%) contained canonical 6-mer
binding motifs for the FKHD, RUNX, and ETS motifs. The few sites that lacked
canonical sites had additional flanking nucleotides that increase statistical
association.
Gene Expression Profiling
GFP+ and GFP CD4 T cells were isolated by CD4 positive selection
(Invitrogen) followed by cell sorting using an Aria2 flow cytometer (BD Biosci-
ences). To ensure high purity, cells were sorted through consecutive rounds of
sorting to attain >99% purity. Cells were resuspended in Trizol, and RNA was
isolated according to manufacturer instructions. Complementary DNA (cDNA)
libraries were amplified and hybridized to Affymetrix MOE 430 2.0 chips.
Arrays were normalized using RMA, and differentially expression was
estimated using the limma package in Bioconductor. Genes were considered
differentially expressed if they had a q value <0.05 after Benjamini-Hochberg
FDR estimation. Significance of differences in gene expression between
sets of genes (e.g., those associated with regions of increased/decreased
chromatin accessibility in Figure 1) was determined by a two-sample Kolmo-
gorov-Smirnov (KS) test, where the background distribution was changed in
all expressed genes unless specified otherwise by dashed line emphasizing
the two cumulative curves being compared.
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